Cargando…

Mechanism of phospho-ubiquitin induced PARKIN activation

The E3 ubiquitin ligase PARKIN (encoded by PARK2) and the protein kinase PINK1 (encoded by PARK6) are mutated in autosomal recessive juvenile Parkinsonism (AR-JP) and work together in the disposal of damaged mitochondria by mitophagy1–3. PINK1 is stabilised on the outside of depolarised mitochondria...

Descripción completa

Detalles Bibliográficos
Autores principales: Wauer, Tobias, Simicek, Michal, Schubert, Alexander, Komander, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984986/
https://www.ncbi.nlm.nih.gov/pubmed/26161729
http://dx.doi.org/10.1038/nature14879
_version_ 1782448007102332928
author Wauer, Tobias
Simicek, Michal
Schubert, Alexander
Komander, David
author_facet Wauer, Tobias
Simicek, Michal
Schubert, Alexander
Komander, David
author_sort Wauer, Tobias
collection PubMed
description The E3 ubiquitin ligase PARKIN (encoded by PARK2) and the protein kinase PINK1 (encoded by PARK6) are mutated in autosomal recessive juvenile Parkinsonism (AR-JP) and work together in the disposal of damaged mitochondria by mitophagy1–3. PINK1 is stabilised on the outside of depolarised mitochondria, and phosphorylates poly-ubiquitin (polyUb)4–8 as well as the PARKIN Ub-like (Ubl) domain9,10. These phosphorylation events lead to PARKIN recruitment to mitochondria, and activation by an unknown allosteric mechanism4–12. Here we present the crystal structure of Pediculus humanus PARKIN in complex with Ser65-phosphorylated ubiquitin (phosphoUb), revealing the molecular basis for PARKIN recruitment and activation. The phosphoUb binding site on PARKIN comprises a conserved phosphate pocket and harbours residues mutated in AR-JP patients. PhosphoUb binding leads to straightening of a helix in the RING1 domain, and the resulting conformational changes release the Ubl domain from the PARKIN core; this activates PARKIN. Moreover, phosphoUb-mediated Ubl release enhances Ubl phosphorylation by PINK1, leading to conformational changes within the Ubl domain and stabilisation of an open, active conformation of PARKIN. We redefine the role of the Ubl domain not only as an inhibitory13 but also as an activating element that is restrained in inactive PARKIN and released by phosphoUb. Our work opens new avenues to identify small molecule PARKIN activators.
format Online
Article
Text
id pubmed-4984986
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-49849862016-08-15 Mechanism of phospho-ubiquitin induced PARKIN activation Wauer, Tobias Simicek, Michal Schubert, Alexander Komander, David Nature Article The E3 ubiquitin ligase PARKIN (encoded by PARK2) and the protein kinase PINK1 (encoded by PARK6) are mutated in autosomal recessive juvenile Parkinsonism (AR-JP) and work together in the disposal of damaged mitochondria by mitophagy1–3. PINK1 is stabilised on the outside of depolarised mitochondria, and phosphorylates poly-ubiquitin (polyUb)4–8 as well as the PARKIN Ub-like (Ubl) domain9,10. These phosphorylation events lead to PARKIN recruitment to mitochondria, and activation by an unknown allosteric mechanism4–12. Here we present the crystal structure of Pediculus humanus PARKIN in complex with Ser65-phosphorylated ubiquitin (phosphoUb), revealing the molecular basis for PARKIN recruitment and activation. The phosphoUb binding site on PARKIN comprises a conserved phosphate pocket and harbours residues mutated in AR-JP patients. PhosphoUb binding leads to straightening of a helix in the RING1 domain, and the resulting conformational changes release the Ubl domain from the PARKIN core; this activates PARKIN. Moreover, phosphoUb-mediated Ubl release enhances Ubl phosphorylation by PINK1, leading to conformational changes within the Ubl domain and stabilisation of an open, active conformation of PARKIN. We redefine the role of the Ubl domain not only as an inhibitory13 but also as an activating element that is restrained in inactive PARKIN and released by phosphoUb. Our work opens new avenues to identify small molecule PARKIN activators. 2015-07-10 2015-08-20 /pmc/articles/PMC4984986/ /pubmed/26161729 http://dx.doi.org/10.1038/nature14879 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Wauer, Tobias
Simicek, Michal
Schubert, Alexander
Komander, David
Mechanism of phospho-ubiquitin induced PARKIN activation
title Mechanism of phospho-ubiquitin induced PARKIN activation
title_full Mechanism of phospho-ubiquitin induced PARKIN activation
title_fullStr Mechanism of phospho-ubiquitin induced PARKIN activation
title_full_unstemmed Mechanism of phospho-ubiquitin induced PARKIN activation
title_short Mechanism of phospho-ubiquitin induced PARKIN activation
title_sort mechanism of phospho-ubiquitin induced parkin activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984986/
https://www.ncbi.nlm.nih.gov/pubmed/26161729
http://dx.doi.org/10.1038/nature14879
work_keys_str_mv AT wauertobias mechanismofphosphoubiquitininducedparkinactivation
AT simicekmichal mechanismofphosphoubiquitininducedparkinactivation
AT schubertalexander mechanismofphosphoubiquitininducedparkinactivation
AT komanderdavid mechanismofphosphoubiquitininducedparkinactivation